Endonovo Therapeutics Inc (ENDV)

[Tkmoney1]

I agree but you have to remember there is simply not enough interest yet, even when we announced those pre-clinical results, the vol should have been way more. We're headed in the right direction eventually, and if we can build another base here, it will set things up for the next run. So it's really a combination of things, lack of coverage, dilution, and flippers keeping this at bay for now.